Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Gemcitabine
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 1000 mg/10 mL
- Dosage form
- Concentrate for infusion
- Pack
- 1's
- Registration no.
- 099015
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Gemontu 1000 mg/10 mL concentrate for infusion
Gemontu 1000 mg/10 mL concentrate for infusion contains Gemcitabine 1000 mg/10 mL. It is registered with DRAP by PUNJAB MEDICAL SERVICES (registration no. 099015). Its official price is PKR 13,819.60 for a pack of 1's. This price has applied since 27 July 2026. Gemontu is also available as 200 mg/2 mL concentrate for solution for infusion. No other brand of Gemcitabine 1000 mg/10 mL in this form is listed in Pakistan.
Other strengths of Gemontu
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 13,819.60, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Gemontu 1000 mg/10 mL, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/gemontu-1000-mg-10-ml-099015-1s-punjab-medical-services/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 13,819.60 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 099015Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
